Mills Roger bought ADXN

September 2, 2026 · Form 4 insider transaction

Mills Roger bought 392,837 shares of Addex Therapeutics Ltd at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
392,837
Price
$0.00
Total value
N/A
Role
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 2, 2026
Filing dateSeptember 4, 2026
Shares owned after785,976
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents 392,837 shares of common Stock listed on SIX Swiss Exchange acquired following the exercise of options. Of these shares, 342,837 were acquired on October 26, 2022 under the deferred strike price payment plan with an initial strike price of $0.16 per share and 50,000 were acquired on November 27, 2023 with an initial strike price of $0.053 per share. On September 2, 2026, following the implementation of the Remuneration Committee's decision, the Strike price of all units was reduced to $0.032. All the other terms of the deferred strike price payment plan remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the exchange act as applicable. The strike prices indicated in this section reflect the conversion from CHF to USD at an exchange rate of $1.2296 per CHF 1.00 as of September 2, 2026

View the original Form 4 on SEC EDGAR
Mills Roger bought ADXN: September 2, 2026 | Insider Trading Screener